An Bras Dermatol. 2013 Nov-Dec;88(6):863-78. doi: 10.1590/abd1806-4841.20132233.
PMID:24474093
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction.
Wei B, Yu Q, Jin J, Zhu D, Lai B, Gu J, Yang R, Huang H, Lin H, Zhang L, Zan T, Xie F, Zhang K, Li Q.
Signal Transduct Target Ther. 2025 May 16;10(1):161. doi: 10.1038/s41392-025-02247-2.
PMID:40374605
Topical therapy for regression and melanoma prevention of congenital giant nevi.
Choi YS, Erlich TH, von Franque M, Rachmin I, Flesher JL, Schiferle EB, Zhang Y, Pereira da Silva M, Jiang A, Dobry AS, Su M, Germana S, Lacher S, Freund O, Feder E, Cortez JL, Ryu S, Babila Propp T, Samuels YL, Zakka LR, Azin M, Burd CE, Sharpless NE, Liu XS, Meyer C, Austen WG Jr, Bojovic B, Cetrulo CL Jr, Mihm MC, Hoon DS, Demehri S, Hawryluk EB, Fisher DE.
Cell. 2022 Jun 9;185(12):2071-2085.e12. doi: 10.1016/j.cell.2022.04.025. Epub 2022 May 12.
PMID:35561684
Giant Congenital Melanocytic Nevus with Congenital Neurofibroma: A Case Report.
Sarkar A, Karmakar D, Saha JK, Saha Basu K, Chatterjee U, Saha K, Mishra DK.